iSpecimen Inc. filed with the Securities and Exchange Commission on October 28, 2022, Margaret H. Lawrence informed the Board of Directors (the “Board”) of the company of her intention to resign as a director of the Company effective November 15, 2022, and as a result, as member of each of the audit committee and the nominating and corporate governance committee of the Company. Ms. Lawrence's services as a member of the Board and of those committees were officially terminated as of November 15, 2022. To fill the vacancy on the Board created by Ms. Lawrence's resignation, the Board, at a Special Meeting of the Board of Directors, held on November 14, 2022, approved the appointment of Joseph J. Basile to serve as a member of the Board and a member of each of the audit committee and nominating and corporate governance committee of the Company, contingent upon and effective as of the date of the finalization of appropriate process regarding such appointment.

Mr. Basile officially began serving as a member of the Board and of each of the audit committee and the nominating and corporate governance committee effective on November 28, 2022. Mr. Basile is replacing Ms. Lawrence as a Class III Director of the Company and his term of office will expire at the Company's 2024 annual meeting of stockholders, unless he is elected at such meeting to serve for another three-year term, or his service on the Board is terminated any time before then. Mr. Basile, age 70, has an extensive body of work with companies and investors in cross-border and domestic mergers, acquisitions, divestitures, financial restructurings, control and minority investments, joint ventures and strategic alliances in North America, Europe, Asia and Latin America.

He has been serving as founder and managing director of Pari Passu M&A Mediation, LLC, an alternative dispute resolution firm, since July 2022, and as a Senior Advisor of Hogan Lovells US LLP, a global law firm, since July 2022. He is also a member of each of the Board of Directors, Executive Committee, and Health Care Task Force of Massachusetts Business Roundtable. Previously, Mr. Basile was a Partner and Co-chair of the Mergers & Acquisitions practice group at Foley Hoag LLP from March 2014 to June 2022.

Prior to that, he worked at Weil, Gotshal & Manges LLP as a Partner and from May 2008 to February 2014 and as Managing Partner of Weil's Boston office from September 2011 to February 2014. From 2000 to 2008, he was a Partner of mergers & acquisitions and financial restructuring practice groups at Bingham McCutchen LLP. Mr. Basile has held several board or committee positions, including as a member of Audit Committee and Finance Committee of Stonehill College, as a member of Board of Trustees of Saint Columbkille Partnership School, and as a member of Massachusetts State Ethics Commission.

He received his A.B. from Stonehill College and J.D. from Harvard Law School. He is well-qualified to serve on the Board due to his extensive experience in mergers & acquisitions and corporate governance.